Valued at $269.0M at its later-stage round, Oct 2025. Nothing has traded since.
- ·The complete investor list: 27 names
- ·Watch Ansa Biotechnologies: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Ansa Biotechnologies funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2024 | Early Stage VC | $46.4M | ▮ | ▮ |
| Apr 2022 | Early Stage VC (Series A) | $68.0M | ▮ | ▮ |
| Oct 2021 | Early Stage VC | $5.0M | ▮ | ▮ |
| Jun 2020 | Seed Round | $4.7M | ▮ | ▮ |
Membership and data by Private Market View
Ansa Biotechnologies valuation
Ansa Biotechnologies was valued at $269 million at its later-stage round in Oct 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Ansa Biotechnologies raised?
Ansa Biotechnologies has raised $140 million across 4 recorded rounds since 2020. The largest was a $68 million Series A in Apr 2022; the most recent was a $46.4 million early-stage round in Jun 2024.
Ansa Biotechnologies has filed 6 Form Ds with the SEC since 2020, most recently in Dec 2025 ($46.4 million sold to 41 investors).
Comparable companies
Comparable biotechnology names by valuation on PrivateMarketView: Ambros Therapeutics ($250 million), Gameto ($243 million) and Antheia ($240 million).
How Ansa Biotechnologies's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Ansa Biotechnologies, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Ansa Biotechnologies
- What is Ansa Biotechnologies worth?
- Ansa Biotechnologies is valued at $269.0M as of Oct 2026. Valued at $269.0M at its later-stage round, Oct 2025. Nothing has traded since.
- How much has Ansa Biotechnologies raised?
- Ansa Biotechnologies has raised $139.6M in total funding across 4 recorded rounds.
- When did Ansa Biotechnologies last raise?
- Ansa Biotechnologies last raised in Jun 2024 (Early Stage VC), raising $46.4M.